- Home
- ANGO vs TALK Comparison
ANGO vs TALK Comparison
Compare ANGO & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- TALK
- Stock Information
- Founded
- ANGO 1988
- TALK 2012
- Country
- ANGO United States
- TALK United States
- Employees
- ANGO N/A
- TALK N/A
- Industry
- ANGO Medical/Dental Instruments
- TALK Medical/Nursing Services
- Sector
- ANGO Health Care
- TALK Health Care
- Exchange
- ANGO Nasdaq
- TALK Nasdaq
- Market Cap
- ANGO 439.5M
- TALK 434.6M
- IPO Year
- ANGO 2004
- TALK N/A
- Fundamental
- Price
- ANGO $9.11
- TALK $3.02
- Analyst Decision
- ANGO Strong Buy
- TALK Buy
- Analyst Count
- ANGO 2
- TALK 6
- Target Price
- ANGO $14.00
- TALK $4.50
- AVG Volume (30 Days)
- ANGO 326.7K
- TALK 1.5M
- Earning Date
- ANGO 04-02-2025
- TALK 05-06-2025
- Dividend Yield
- ANGO N/A
- TALK N/A
- EPS Growth
- ANGO N/A
- TALK N/A
- EPS
- ANGO N/A
- TALK 0.02
- Revenue
- ANGO $283,320,000.00
- TALK $194,359,000.00
- Revenue This Year
- ANGO N/A
- TALK $23.21
- Revenue Next Year
- ANGO $6.35
- TALK $20.87
- P/E Ratio
- ANGO N/A
- TALK $173.65
- Revenue Growth
- ANGO N/A
- TALK 19.88
- 52 Week Low
- ANGO $5.47
- TALK $1.60
- 52 Week High
- ANGO $13.50
- TALK $4.36
- Technical
- Relative Strength Index (RSI)
- ANGO 46.41
- TALK 52.96
- Support Level
- ANGO $8.55
- TALK $2.75
- Resistance Level
- ANGO $9.68
- TALK $3.30
- Average True Range (ATR)
- ANGO 0.36
- TALK 0.19
- MACD
- ANGO -0.02
- TALK 0.00
- Stochastic Oscillator
- ANGO 46.28
- TALK 58.82
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.